4//SEC Filing
Mohan Raju 4
Accession 0001209191-23-059234
CIK 0001851194other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 5:30 PM ET
Size
10.3 KB
Accession
0001209191-23-059234
Insider Transaction Report
Form 4
Mohan Raju
DirectorCEO AND PRESIDENT
Transactions
- Exercise/Conversion
Common Stock
2023-12-17+116,668→ 1,629,579 total - Exercise/Conversion
Restricted Stock Units
2023-12-17−116,668→ 233,336 total→ Common Stock (116,668 underlying) - Award
Stock Option (Right to Buy)
2023-12-18+473,750→ 473,750 totalExercise: $2.14Exp: 2033-12-18→ Common Stock (473,750 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Ventyx Biosciences, Inc. common stock.
- [F2]Subject to the reporting person's continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through such applicable vesting date, twenty five percent (25%) of the RSUs subject to the award shall vest on the one (1) year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the RSUs subject to the award shall vest on each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean December 17, 2021.
- [F3]One forty-eighth (1/48th) of the total shares subject to the Option shall vest each month following December 18, 2023 (the "Vesting Commencement Date") on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the reporting person continuing to be a Service Provider, as defined in the Company's 2021 Equity Incentive Plan (the "Plan") through each such date.
Documents
Issuer
Ventyx Biosciences, Inc.
CIK 0001851194
Entity typeother
Related Parties
1- filerCIK 0001878125
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 5:30 PM ET
- Size
- 10.3 KB